Document Detail


Enhanced efficacy of amodiaquine and chlorpheniramine combination over amodiaquine alone in the treatment of acute uncomplicated Plasmodium falciparum malaria in children.
MedLine Citation:
PMID:  18408387     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To evaluate the comparative efficacy of amodiaquine (AMQ) alone and the combination of AMQ and chlorpheniramine (CP) in the treatment of acute uncomplicated malaria in children. SUBJECTS: Of the 110 children enrolled in the study, 103 with acute uncomplicated malaria, aged 6 months to 12 years, were evaluated using the 14-day modification of the WHO field test. The patients were randomized to 2 groups. Group 1 received supervised treatment with AMQ alone (10 mg AMQ base/kg daily for 3 days), while group 2 received supervised treatment with AMQ (same dose as group 1) plus CP (AMQCP) for 7 days. RESULTS: Both treatment regimens were well tolerated and no patient was withdrawn as a result of recurrent vomiting or drug-related adverse events. There was no significant difference in mean fever and parasite clearance times. The cure rates at day 7 were 90.2 versus 100% (rho = 0.027) for AMQ versus AMQCP, while the day 14 cure rates were 85.9 versus 98.1% for AMQ versus AMQCP, respectively (rho = 0.016). CONCLUSION: The combination of AMQ plus CP proved significantly more effective than AMQ alone in the treatment of acute uncomplicated falciparum malaria, most probably due to the enhancement of the antimalarial effect of AMQ by CP. The combination of AMQCP could be a better alternative to AMQ alone as a companion drug in artemisinin-based combination therapies.
Authors:
C O Falade; S O Michael; A M J Oduola
Related Documents :
16553917 - The spectrum of hypoxaemia in children admitted to hospital in the gambia, west africa.
18831737 - Impact of training in clinical and microscopy diagnosis of childhood malaria on antimal...
19735557 - Pfhrp2 and pfldh antigen detection for monitoring the efficacy of artemisinin-based com...
10974167 - In vivo sensitivity of plasmodium falciparum to chloroquine and sulfadoxine-pyrimethami...
696277 - Hip joint instability after the neonatal period. diagnosis and treatment of 20 consecut...
12508157 - Long-term immunogenicity and efficacy of universal hepatitis b virus vaccination in tai...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2008-04-10
Journal Detail:
Title:  Medical principles and practice : international journal of the Kuwait University, Health Science Centre     Volume:  17     ISSN:  1423-0151     ISO Abbreviation:  Med Princ Pract     Publication Date:  2008  
Date Detail:
Created Date:  2008-04-14     Completed Date:  2008-06-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8901334     Medline TA:  Med Princ Pract     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  197-201     Citation Subset:  IM    
Copyright Information:
(c) 2008 S. Karger AG, Basel
Affiliation:
Department of Pharmacology, College of Medicine, University of Ibadan, Ibadan, Nigeria. fallady@skannet.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Amodiaquine / administration & dosage,  adverse effects,  therapeutic use*
Animals
Antimalarials / administration & dosage,  adverse effects,  therapeutic use*
Child
Child, Preschool
Chlorpheniramine / administration & dosage,  adverse effects,  therapeutic use*
Drug Therapy, Combination
Female
Humans
Infant
Malaria, Falciparum / drug therapy*,  physiopathology
Male
Nigeria
Plasmodium falciparum* / drug effects
Prospective Studies
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antimalarials; 132-22-9/Chlorpheniramine; 86-42-0/Amodiaquine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Experimental colitis is associated with ultrastructural changes in inflamed and uninflamed regions o...
Next Document:  C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.